vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and ON24 INC. (ONTF). Click either name above to swap in a different company.
ON24 INC. is the larger business by last-quarter revenue ($34.6M vs $31.1M, roughly 1.1× LIFECORE BIOMEDICAL, INC. \DE\). ON24 INC. runs the higher net margin — -18.8% vs -32.1%, a 13.4% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -5.6%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-2.2M). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -4.2%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
ON24 Inc., a San Francisco-based company, is a cloud-based platform that develops and sells web-based webinar, virtual conferencing, content hub, and landing page applications as a service for marketing and sales teams in B2B organizations. In 2023 it expanded its offerings to include generative AI services.
LFCR vs ONTF — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $34.6M |
| Net Profit | $-10.0M | $-6.5M |
| Gross Margin | 25.0% | 74.9% |
| Operating Margin | -9.9% | -23.5% |
| Net Margin | -32.1% | -18.8% |
| Revenue YoY | -4.5% | -5.6% |
| Net Profit YoY | -52.0% | 26.8% |
| EPS (diluted) | $-0.29 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $34.6M | ||
| Q3 25 | $31.1M | $34.6M | ||
| Q2 25 | — | $35.3M | ||
| Q1 25 | $35.2M | $34.7M | ||
| Q4 24 | $32.6M | $36.7M | ||
| Q3 24 | $24.7M | $36.3M | ||
| Q2 24 | — | $37.3M | ||
| Q1 24 | $35.7M | $37.7M |
| Q4 25 | — | $-6.5M | ||
| Q3 25 | $-10.0M | $-6.4M | ||
| Q2 25 | — | $-7.3M | ||
| Q1 25 | $-14.8M | $-8.7M | ||
| Q4 24 | $-6.6M | $-8.9M | ||
| Q3 24 | $-16.2M | $-11.4M | ||
| Q2 24 | — | $-11.2M | ||
| Q1 24 | $15.6M | $-10.7M |
| Q4 25 | — | 74.9% | ||
| Q3 25 | 25.0% | 74.7% | ||
| Q2 25 | — | 75.1% | ||
| Q1 25 | 28.0% | 73.8% | ||
| Q4 24 | 34.0% | 74.5% | ||
| Q3 24 | 21.8% | 74.3% | ||
| Q2 24 | — | 74.5% | ||
| Q1 24 | 33.3% | 74.1% |
| Q4 25 | — | -23.5% | ||
| Q3 25 | -9.9% | -23.1% | ||
| Q2 25 | — | -26.0% | ||
| Q1 25 | -25.7% | -30.1% | ||
| Q4 24 | -6.0% | -32.1% | ||
| Q3 24 | -46.9% | -36.7% | ||
| Q2 24 | — | -35.0% | ||
| Q1 24 | -2.5% | -33.1% |
| Q4 25 | — | -18.8% | ||
| Q3 25 | -32.1% | -18.4% | ||
| Q2 25 | — | -20.6% | ||
| Q1 25 | -42.0% | -25.1% | ||
| Q4 24 | -20.2% | -24.2% | ||
| Q3 24 | -65.7% | -31.4% | ||
| Q2 24 | — | -29.9% | ||
| Q1 24 | 43.8% | -28.4% |
| Q4 25 | — | $-0.15 | ||
| Q3 25 | $-0.29 | $-0.15 | ||
| Q2 25 | — | $-0.17 | ||
| Q1 25 | $-0.47 | $-0.21 | ||
| Q4 24 | $-0.25 | $-0.21 | ||
| Q3 24 | $-0.53 | $-0.27 | ||
| Q2 24 | — | $-0.27 | ||
| Q1 24 | $0.42 | $-0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $37.0M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $139.4M |
| Total Assets | $235.2M | $228.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $37.0M | ||
| Q3 25 | $18.9M | $47.2M | ||
| Q2 25 | — | $37.7M | ||
| Q1 25 | $5.4M | $26.8M | ||
| Q4 24 | $9.5M | $14.9M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $15.5M | ||
| Q1 24 | — | $18.3M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $139.4M | ||
| Q3 25 | $-10.5M | $144.3M | ||
| Q2 25 | — | $150.0M | ||
| Q1 25 | $2.2M | $153.7M | ||
| Q4 24 | $15.4M | $159.4M | ||
| Q3 24 | $-3.9M | $164.9M | ||
| Q2 24 | — | $170.8M | ||
| Q1 24 | $17.7M | $174.4M |
| Q4 25 | — | $228.4M | ||
| Q3 25 | $235.2M | $224.8M | ||
| Q2 25 | — | $235.1M | ||
| Q1 25 | $237.7M | $245.8M | ||
| Q4 24 | $255.4M | $251.0M | ||
| Q3 24 | $246.8M | $250.9M | ||
| Q2 24 | — | $259.0M | ||
| Q1 24 | $246.2M | $269.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $-1.1M |
| Free Cash FlowOCF − Capex | $25.0K | $-2.2M |
| FCF MarginFCF / Revenue | 0.1% | -6.4% |
| Capex IntensityCapex / Revenue | 5.6% | 3.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $4.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.1M | ||
| Q3 25 | $1.8M | $2.5M | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | $1.2M | $3.4M | ||
| Q4 24 | $-6.1M | $985.0K | ||
| Q3 24 | $-613.0K | $295.0K | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | $-1.4M | $2.1M |
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $25.0K | $2.2M | ||
| Q2 25 | — | $2.1M | ||
| Q1 25 | $-4.3M | $1.9M | ||
| Q4 24 | $-8.6M | $424.0K | ||
| Q3 24 | $-4.0M | $143.0K | ||
| Q2 24 | — | $898.0K | ||
| Q1 24 | $-7.8M | $1.1M |
| Q4 25 | — | -6.4% | ||
| Q3 25 | 0.1% | 6.2% | ||
| Q2 25 | — | 5.9% | ||
| Q1 25 | -12.1% | 5.6% | ||
| Q4 24 | -26.3% | 1.2% | ||
| Q3 24 | -16.3% | 0.4% | ||
| Q2 24 | — | 2.4% | ||
| Q1 24 | -21.8% | 2.9% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | 5.6% | 1.1% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | 15.5% | 4.2% | ||
| Q4 24 | 7.5% | 1.5% | ||
| Q3 24 | 13.9% | 0.4% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | 17.8% | 2.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
ONTF
Segment breakdown not available.
